Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.

@article{Gl2004EffectsOA,
  title={Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.},
  author={Feyzullah G{\"u}çl{\"u} and Bilgin Ozmen and Zeliha Hekimsoy and Cengiz Kirmaz},
  journal={Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
  year={2004},
  volume={58 10},
  pages={614-8}
}
BACKGROUND In West of Scotland Coronary Prevention Study (WOSCOPS), development of type 2 diabetes mellitus (DM) was found to decrease by 30% in pravastatin-treated patients. In the study, it is suggested that pleiotropic effects of pravastatin may be responsible too as well as its lipid lowering effect. OBJECTIVE The aim of this study was to assess the effects of pravastatin treatment on the insulin resistance in patients with metabolic syndrome with impaired glucose tolerance (IGT), by… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Differential effects of pravastatin on the pharmacokinetics of paroxetine in normal and diabetic rats.

Xenobiotica; the fate of foreign compounds in biological systems • 2017
View 4 Excerpts
Highly Influenced

Diabetogenic Effect of Statins: A Double-Edged Sword?

Diabetes & metabolism journal • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…